Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma 6Colorectal Neoplasms 6Stomach Neoplasms 5Rectal Neoplasms 5Colonic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2HIV Infections 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Acquired Immunodeficiency Syndrome 2Sezary Syndrome 1Peritoneal Neoplasms 1Neoplastic Cells, Circulating 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hydatidiform Mole, Invasive 1Gestational Trophoblastic Disease 1Gastrointestinal Neoplasms 1Choriocarcinoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Appendiceal Neoplasms 1

Interventions

Methotrexate 1Leucovorin 1Dactinomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hydatidiform Mole, Invasive × Leucovorin × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡